Cargando…
Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies
Toxoplasma gondii is the etiologic agent of toxoplasmosis, a disease which can lead to morbidity and mortality of the fetus and immunocompromised individuals. Due to the limited effectiveness or side effects of existing drugs, the search for better drug candidates is still ongoing. In this study, we...
Autores principales: | Salin, Nurul Hanim, Noordin, Rahmah, Al-Najjar, Belal O., Kamarulzaman, Ezatul Ezleen, Yunus, Muhammad Hafiznur, Karim, Izzati Zahidah Abdul, Nasim, Nurul Nadieya Mohd, Zakaria, Iffah Izzati, Wahab, Habibah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244133/ https://www.ncbi.nlm.nih.gov/pubmed/32442170 http://dx.doi.org/10.1371/journal.pone.0225232 |
Ejemplares similares
-
Computational study of nitro-benzylidene phenazine as dengue virus-2 NS2B-NS3 protease inhibitor
por: Salin, Nurul Hanim, et al.
Publicado: (2022) -
Identification and real-time expression analysis of selected Toxoplasma gondii in-vivo induced antigens recognized by IgG and IgM in sera of acute toxoplasmosis patients
por: Amerizadeh, Atefeh, et al.
Publicado: (2013) -
Antibody-Based Protective Immunity against Helminth Infections: Antibody Phage Display Derived Antibodies against BmR1 Antigen
por: Rahumatullah, Anizah, et al.
Publicado: (2017) -
3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors
por: Osman, Hasnah, et al.
Publicado: (2017) -
Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach
por: Norshidah, Harun, et al.
Publicado: (2023)